Analyst firms · BofA Securities · PANW

BofA Securities PANW price target and rating history

Palo Alto Networks Inc. (PANW) · Technology

BofA Securities rates Palo Alto Networks Inc. (PANW) Buy with a $215 price target, as of its latest action on Aug 19, 2025. It has published 3 rating actions on PANW since November 2023, including 1 upgrade and 1 downgrade. Across 8 firms with a PANW price target in the last 12 months, the median target is $343.

Current rating
Buy
Price target
$215
Median target, all firms
$343
Actions on PANW
3

BofA Securities price target on PANW

$430$323$21520252026
BofA Securities price target on PANW, each point a stated target, November 2024 to August 2025.

Every BofA Securities rating on PANW

How other firms rate PANW

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
KeyBanc Capital MarketsOverweight$380Nov 13, 2026
BernsteinMkt Perform$351Sep 17, 2026
WedbushOutperform$400Sep 11, 2026
Capital OneOverweight$421Jul 16, 2026
BMO Capital MarketsOutperform$335Jun 3, 2026
BerenbergBuy$215Apr 21, 2026
Arete ResearchBuy$185Mar 3, 2026
GuggenheimNeutralJan 5, 2026
HSBCReduce$157Nov 21, 2025

Questions about BofA Securities and PANW

What is BofA Securities's price target for PANW?
BofA Securities's latest stated price target for Palo Alto Networks Inc. (PANW) is $215, from its action on Aug 19, 2025.
What is BofA Securities's rating on PANW?
BofA Securities rates PANW Buy, a bullish rating, as of Aug 19, 2025.
When did BofA Securities last change its view on PANW?
On Aug 19, 2025, BofA Securities upgrades to Buy from Neutral, price target $215.
How does BofA Securities's PANW target compare with other analysts?
Across 8 firms with a PANW price target in the last 12 months, the median target is $343.

More PANW rating histories

All BofA Securities ratingsPANW news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.